Daily Download

ISR2.jpg

Injection Site Reactions

Jack Cush, MD
ISRs are common with biologic use
Total%20Biosimilars.Updated.1219.jpg

Even More Biosimilars

Jack Cush, MD
Updated Biosimilars in the US: 11 TNFi and 2 RTX biosimilars
NPQ.jpg

New Patient Intake/Survey Form

Jack Cush, MD
AOSD.ACR_.MTP_.2019.jpg

Adult Stills Disease & Febrile Disorders

Jack Cush, MD
Slide set on Febrile Disorders and AOSD from ACR19
Biosimilars.Updated.1119.jpg

New Biosimilars for Rheumatology - 2019

Jack Cush, MD
4 Slides Reviewing 11 Biosimilars Approved and Indications
Adverse%20Effects%20new%20agents%20Oct%202019.Cush_.jpg

Adverse Effects of Newer Agents 2019

Jack Cush, MD
Safety of Biologics and JAKS - KRA 2019 Presentation
ISR.jpg

Biologic Injection Site Reactions

Jack Cush, MD
ISRs Related to IL-1 inhibitors and TNF inhibitors
RF%2CCCP.Rules__0.jpg

RF/CCP Rules for Use

Jack Cush, MD
New.Biosimilars.0719.jpg

anti-TNF Biosimilars in USA

Jack Cush, MD
UPDATED - there are now 9 biosimilar versions of TNF inhibitors
Screen%20Shot%202019-07-08%20at%202.57.04%20PM.png

RA and Comorbidities

Tammy J. Tilley
3EFAE286-B1EE-442D-8AD1-FEF46F88B9E2.jpeg

Vaccination Deficit in Rheumatology

Tammy J. Tilley
Rhupus.jpg

Comparison of Rhupus and RA

Jack Cush, MD

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×